Lynch syndrome, also known as hereditary non-polyposis colorectal cancer, is characterized by an increased risk for colorectal cancer and endometrial cancer associated with pathogenic or likely pathogenic variants in DNA mismatch repair genes (MLH1, MSH2, MSH6, PMS2) and EPCAM (33). The gene discussed is PMS2; the disease is hereditary nonpolyposis colon cancer.